ArticlePharmaceutics2021

HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy.

Marina R Tavares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.